Your Hormones and Your Weight: What’s Actually Happening
Weight changes during perimenopause and menopause aren’t about willpower. Here’s the hormonal biology behind what’s happening — and what you can actually do about it.
The complaint I hear most often from women in their 40s and 50s is some version of this: “I’m doing everything the same and my body is respondng differently.” Same food, same activity, weight creeping up — especially around the middle. And they want to know what they did wrong.
Nothing. They didn’t do anything wrong. Their hormones changed, and nobody told them that would affect everything from where they store fat to how well they sleep to how hungry they feel. That gap in information is something I take seriously, because it sends a lot of women down the wrong path — blaming themselves, cutting more, pushing harder — when the actual issue is biological.
Why does weight change during perimenopause and menopause?
The short answer is estrogen. Estrogen plays a significant role in fat distribution, and as it declines during perimenopause and menopause, that pattern shifts. During your reproductive years, estrogen tends to direct fat storage toward the hips and thighs. As levels drop, storage moves toward the abdomen — and this happens even in women whose total body weight stays the same.
Abdominal fat isn’t just a cosmetic change. It’s associated with increased cardiovascular risk, metabolic disruption, and insulin resistance. Which is why this conversation matters beyond how clothes fit.
What happens to muscle during menopause?
Women lose up to 3 to 8 percent of muscle mass per decade after age 30, and that rate accelerates during perimenopause. Muscle is metabolically active tissue — it burns more calories at rest than fat does. As muscle mass declines, metabolic rate declines with it. The same food intake and activity level that maintained your weight at 35 may not do the same at 45 or 50. That’s not a failure of discipline. It’s a change in body composition driven by hormonal decline.
Estrogen also has a protective effect on muscle tissue. As it drops, so does some of that protection. This is one reason resistance training becomes increasingly important during this phase of life — not just for fitness, but for metabolic health.
Why does sleep affect weight during perimenopause?
Progesterone supports sleep, and sleep is tightly connected to appetite regulation. When progesterone declines — which often happens before estrogen does — sleep quality drops. Poor sleep increases ghrelin, the hormone that signals hunger, and decreases leptin, the hormone that signals fullness. The result is that appetite becomes harder to manage, often without any change in behavior.
This is not a willpower problem. It is a hormonal feedback loop. I want women to understand that distinction, because it changes how you respond to it.
Does menopause affect insulin sensitivity?
Yes. Estrogen influences how efficiently your body manages blood sugar. As estrogen declines, insulin sensitivity can decrease — which affects both fat storage and appetite. This is part of why some women notice in midlife that foods they never had issues with before suddenly seem to hit differently. Carbohydrate tolerance can shift, and it may have a hormonal explanation.
What about GLP-1 medications during perimenopause?
For women already using GLP-1 medications for weight management, the hormonal picture matters. GLP-1 medications address appetite and blood sugar regulation effectively, but they work within a body that is also being affected by declining estrogen. Muscle preservation becomes a particular focus — the emphasis on adequate protein and resistance training during GLP-1 therapy is even more relevant when estrogen-driven muscle loss is also occurring.
Research on tirzepatide in menopausal and postmenopausal women shows that when GLP-1 therapy and hormone therapy are used together, women tend to have better clinical outcomes. These systems interact. A care plan that accounts for both is going to be more effective than one that treats them as separate conversations.
What can you actually do about weight changes during menopause?
A few things make a real difference, and none of them are about eating less and moving more in the generic sense.
Protein intake matters more during this phase than most women realize. Adequate protein supports muscle preservation, helps regulate appetite, and works with the metabolic changes that are happening. Most women are eating less protein than their bodies benefit from, particularly as caloric intake shifts with age.
Resistance training is not optional. Cardiovascular exercise matters for heart health, but resistance training is what preserves and builds muscle mass. Two to three sessions per week is a meaningful target.
Sleep is a metabolic necessity, not a lifestyle bonus. Addressing sleep disruption — which often has a hormonal component — can have a direct effect on appetite, energy, and body composition.
Hormone therapy is worth a real conversation. For women who are candidates, addressing estrogen and progesterone decline can support metabolic health, not just symptom relief. If your current provider hasn’t raised it, ask. The evidence has shifted significantly over the past decade, and the default position of avoiding hormone therapy in otherwise healthy perimenopausal women is increasingly out of step with where the science is.
If your current approach isn’t accounting for your hormonal picture, it’s missing part of the story.
Dr. Jessica Duncan is the Chief Medical Officer at Ivim Health, a physician-led virtual metabolic health company operating across 49 states. She is board-certified in obesity medicine and has published peer-reviewed research on GLP-1 outcomes in Obesity Pillars.
Disclaimer:
Medical Advice: This content is for informational purposes only and does not constitute medical advice. Always consult with a licensed healthcare provider regarding your health needs, diagnosis, and medication management.
Sources:
Castaneda, Regina, et al. “The Role of Menopause Hormone Therapy in Modulating Tirzepatide-Associated Weight Loss in Postmenopausal Women With Overweight or Obesity: A Retrospective Cohort Study.” The Lancet Obstetrics, Gynaecology & Women’s Health, vol. 2, no. 2, 2026, pp. e118–e128. Elsevier, https://doi.org/10.1016/S3050-5038(25)00145-1.
